Page 67 - JCTR-11-5
P. 67

Journal of Clinical and
            Translational Research                                          Metabolism of healthy and leukemic stem cells



            and LSC survival but also highlight specific bioenergetic   Visualization: Gavin M. Traber, Emely A. Pacheco, Edziu
            vulnerabilities within LSCs that may serve as therapeutic   Franczak, Ansh Kumar
            targets. By gaining a deeper understanding of the metabolic   Writing–original draft: Gavin M. Traber, Emely A. Pacheco,
            characteristics that distinguish healthy HSC activity   Edziu Franczak, Ansh Kumar
            from  dysregulated LSC  activity,  researchers  can better   Writing–review & editing: Gavin M. Traber, Emely A.
            understand the mechanisms that sustain healthy function   Pacheco, Edziu Franczak, Kelsey H. Fisher-Wellman,
            and identify those that lead to oncogenic transformation   Kathleen M. Sakamoto
            and other hematological disorders.
              Collectively, these findings suggest that while LSCs are   Ethics approval and consent to participate
            metabolically altered for survival, these unique adaptations   Not applicable.
            may serve as targets for therapeutic intervention. Strategies
            that impair mitochondrial metabolism disrupt FAO or target   Consent for publication
            nutrient-sensing pathways may offer promising approaches   Not applicable.
            for selectively eliminating LSCs without compromising
            healthy hematopoiesis. As our understanding of stem   Availability of data
            cell metabolism deepens, these insights will guide the   Not applicable.
            development of next-generation therapies to improve
            treatment durability and prevent relapse in hematologic   References
            malignancies such as AML and CML.
                                                               1.   Olson OC, Kang YA, Passegue E. Normal hematopoiesis is a
            Acknowledgments                                       balancing act of self-renewal and regeneration. Cold Spring
                                                                  Harb Perspect Med. 2020;10(12):a035519.
            None.
                                                                  doi: 10.1101/cshperspect.a035519
            Funding                                            2.   Morrison SJ, Scadden DT. The bone marrow niche for
                                                                  haematopoietic stem cells. Nature. 2014;505(7483):327-334.
            Gavin M. Traber is supported by the National Institute
            of Diabetes and Digestive and Kidney Diseases (NIDDK;      doi: 10.1038/nature12984
            TL1DK139565).  Kathleen  M.  Sakamoto  is funded  by   3.   Barreto  IV,  Pessoa  F, Machado  CB,  et al.  Leukemic  stem
            NIDDK (DK136961), the Leukemia and Lymphoma           cell: A  mini-review on clinical perspectives.  Front Oncol.
            Society (R6518-23), the Pediatric Cancer Research     2022;12:931050.
            Foundation (grant number: 858010), the Stanford       doi: 10.3389/fonc.2022.931050
            Innovation Medicine Accelerator, Cure Childhood Cancer
            (grant number: 641095), and the Department of Defense   4.   Seita J, Weissman IL. Hematopoietic stem cell: Self-renewal
            (RA220017).  Emely  A.  Pacheco  and  Kelsey  H.  Fisher-  versus differentiation. Wiley Interdiscip Rev Syst Biol Med.
                                                                  2010;2(6):640-653.
            Wellman are supported by the National Cancer Institute
            (P01CA171983 and R01CA299332). Emely A. Pacheco,      doi: 10.1002/wsbm.86
            Edziu  Franczak,  and  Kelsey  H.  Fisher-Wellman  are   5.   Morganti C, Cabezas-Wallscheid N, Ito K. Metabolic
            supported by the National Cancer Institute (P01CA171983   regulation of hematopoietic stem cells.  Hemasphere.
            and R01CA299332).                                     2022;6(7):e740.
            Conflict of interest                                  doi: 10.1097/HS9.0000000000000740
                                                               6.   Mann Z, Sengar M, Verma YK, Rajalingam R, Raghav PK.
            Kathleen M. Sakamoto is an Editorial Board Member of   Hematopoietic stem cell factors: Their functional role
            this journal, but was not in any way involved in the editorial   in self-renewal and clinical aspects.  Front Cell Dev Biol.
            and peer-review process conducted for this paper, directly   2022;10:664261.
            or indirectly. Separately, other authors declared that they      doi: 10.3389/fcell.2022.664261
            have no known competing financial interests or personal
            relationships that could have influenced the work reported   7.   Zhang CC, Lodish HF. Cytokines regulating hematopoietic
            in this paper.                                        stem cell function. Curr Opin Hematol. 2008;15(4):307-311.
                                                                  doi: 10.1097/MOH.0b013e3283007db5
            Author contributions
                                                               8.   Simsek T, Kocabas F, Zheng J, et al. The distinct metabolic
            Conceptualization: Gavin M. Traber, Emely A. Pacheco,   profile of hematopoietic stem cells reflects their location in a
               Kelsey H. Fisher-Wellman, Kathleen M. Sakamoto     hypoxic niche. Cell Stem Cell. 2010;7(3):380-390.


            Volume 11 Issue 5 (2025)                        61                         doi: 10.36922/JCTR025320053
   62   63   64   65   66   67   68   69   70   71   72